Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 19,550
- Value
- $71.7K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,550 | $71.7K | <0.1% | +6,950+55.2% | Added | Holders |
| Q1 2026 | 12,600 | $38.7K | <0.1% | −15,150−54.6% | Reduced | Holders |
| Q4 2025 | 27,750 | $113.5K | <0.1% | −896−3.1% | Reduced | Holders |
| Q3 2025 | 28,646 | $139.8K | <0.1% | −15,904−35.7% | Reduced | Holders |
| Q2 2025 | 44,550 | $225.4K | <0.1% | +680+1.6% | Added | Holders |
| Q1 2025 | 43,870 | $232.1K | <0.1% | +43,870 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −13,500−100.0% | Sold out | Holders |
| Q1 2024 | 13,500 | $134.6K | <0.1% | +13,500 | New | Holders |